Current Vaccine Clinical Studies
We are currently enrolling volunteers for a range of studies. If you are interested in volunteering to participate in a clinical trial, please call us at 1-866-833-LIFE (5433) or e-mail us at VRCforlife@mail.nih.gov.
Studies Open to Accrual
These studies are recruiting.
VRC Clinical Trials Related to Development of Vaccines for Prevention of HIV
VRC 000 (02-I-0127):
Screening Subjects for HIV Vaccine Research Studies
VRC 012 (07-I-0167):
A Phase I Clinical Trial of the Safety and Immunogenicity of an HIV-1 Adenoviral Vector Serotype 35 Vaccine, VRC-HIVADV027-00-VP (rAd35-EnvA): Dose Escalation as a Single Agent and Prime-Boost Schedules with an HIV-1 Adenoviral Vector Serotype 5 Vaccine, VRC-HIVADV038-00-VP (rAd5-EnvA), in Uninfected Adults
VRC Clinical Trials Related to Vaccines for Biodefense and Emerging Pathogens
VRC 300 (03-I-0285):
Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases
VRC 205 (06-I-0237):
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Recombinant Ebola Adenoviral Vector Vaccine, VRC-EBOADV018-00-VP, in Healthy Adults
VRC 206 (08-I-0065)
A Phase I Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults
VRC 306 (09-I-0012):
An Open-Label, Randomized Phase I Study in Healthy Adults of Four Prime-Boost Schedules with Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc), Administered Alone or Following Recombinant DNA Plasmid (H5) Vaccine, VRC-AVIDNA036-00-VP (VRC, NIAID)
These studies are not recruiting.
VRC Protocols to Obtain Laboratory Samples for Vaccine and Immunology Research
VRC 200 (03-I-0263):
Apheresis Procedures to Obtain Plasma or Peripheral Blood Mononuclear Cells (PBMCs) for Research Studies
VRC Clinical Trials Related to Development of Vaccines for Treatment of HIV
VRC 100 (03-I-0079):
Screening HIV-Infected Subjects for Vaccine Research Studies
back to top